PTGS2 and central nervous system cancer: Although each of these mechanisms has not been specifically studied in gliomas, Joki et al. demonstrated that NS-398, a COX-2-specific inhibitor, increased apoptosis, reduced proliferation, and attenuated invasion of cultured human glioma cells [68].